Hazard characterisation of chemicals in food and diet. dose response, mechanisms and extrapolation issues.

Hazard characterisation of low molecular weight chemicals in food and diet generally use a no-observed-adverse-effect level (NOAEL) or a benchmark dose as the starting point. For hazards that are considered not to have thresholds for their mode of action, low-dose extrapolation and other modelling approaches may be applied. The default position is that rodents are good models for humans. However, some chemicals cause species-specific toxicity syndromes. Information on quantitative species differences is used to modify the default uncertainty factors applied to extrapolate from experimental animals to humans. A central theme for extrapolation is unravelling the mode of action for the critical effects observed. Food can be considered as an extremely complex and variable chemical mixture. Interactions among low molecular weight chemicals are expected to be rare given that the exposure levels generally are far below their NOAELs. Hazard characterisation of micronutrients must consider that adverse effects may arise from intakes that are too low (deficiency) as well as too high (toxicity). Interactions between different nutrients may complicate such hazard characterisations. The principle of substantial equivalence can be applied to guide the hazard identification and hazard characterisation of macronutrients and whole foods. Macronutrients and whole foods must be evaluated on a case-by-case basis and cannot follow a routine assessment protocol.

[1]  J. Caldwell,et al.  The current status of attempts to predict species differences in drug metabolism. , 1981, Drug metabolism reviews.

[2]  K. Soper,et al.  The effects of diet, overfeeding and moderate dietary restriction on Sprague-Dawley rat survival, disease and toxicology. , 1997, The Journal of nutrition.

[3]  B. Henderson,et al.  Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma , 1992, The Lancet.

[4]  J. Groten,et al.  Changes in the Nasal Epithelium of Rats Exposed by Inhalation to Mixtures of Formaldehyde, Acetaldehyde, and Acrolein , 1996 .

[5]  W. Dekant,et al.  Bioactivation of nephrotoxins and renal carcinogens by glutathione S-conjugate formation. , 1993, Toxicology letters.

[6]  F. Lu,et al.  Acceptable daily intake: inception, evolution, and application. , 1988, Regulatory toxicology and pharmacology : RTP.

[7]  J. Swenberg,et al.  Biochemical Mechanisms and Pathobiology of α2u-Globulin Nephropathy , 1990 .

[8]  L. Bernstein,et al.  Interspecies extrapolation in carcinogenesis: prediction between rats and mice. , 1989, Environmental health perspectives.

[9]  J. Schenkman,et al.  Physiological and pathophysiological alterations in rat hepatic cytochrome P-450. , 1989, Drug metabolism reviews.

[10]  Eric D. Schoen,et al.  Subacute Toxicity of a Mixture of Nine Chemicals in Rats: Detecting Interactive Effects with a Fractionated Two-Level Factorial Design , 1997 .

[11]  G. Williamson,et al.  Mechanism of action of dietary chemoprotective agents in rat liver: induction of phase I and II drug metabolizing enzymes and aflatoxin B1 metabolism. , 1997, Carcinogenesis.

[12]  A. Tischler,et al.  Low digestible carbohydrates (polyols and lactose): significance of adrenal medullary proliferative lesions in the rat. , 1996, Regulatory toxicology and pharmacology : RTP.

[13]  R. Ings,et al.  Interspecies scaling and comparisons in drug development and toxicokinetics. , 1990, Xenobiotica; the fate of foreign compounds in biological systems.

[14]  C T De Rosa,et al.  Estimation of toxicity of chemical mixtures through modeling of chemical interactions. , 1998, Environmental health perspectives.

[15]  W. Dekant,et al.  Glutathione-dependent toxicity. , 1992, Xenobiotica; the fate of foreign compounds in biological systems.

[16]  L. Lave Risk Assessment and Management , 2013, Advances in Risk Analysis.

[17]  Scientific evaluation of the data-derived safety factors for the acceptable daily intake. Case study: diethylhexylphthalate. , 1993, Food additives and contaminants.

[18]  M. Ellis,et al.  The role of glutathione conjugation in the development of kidney tumours in rats exposed to trichloroethylene. , 1997, Chemico-biological interactions.

[19]  L B Ellwein,et al.  The health risks of saccharin revisited. , 1990, Critical reviews in toxicology.

[20]  B. P. Mcnamara,et al.  Concepts in health evaluation of commercial and industrial chemicals , 1975 .

[21]  C. S. Weil,et al.  Safety Evaluation of Chemicals, Relationship between Short-and Long-Term Feeding Studies in Designing an Effective Toxicity Test , 1963 .

[22]  P. Hepburn,et al.  Safety evaluation of phytosterol esters. Part 2. Subchronic 90-day oral toxicity study on phytosterol esters--a novel functional food. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[23]  T. Onodera,et al.  Antithyroid effects of propylthiouracil and sulfamonomethoxine in rats and monkeys. , 1986, Toxicology and applied pharmacology.

[24]  A. Hartwig,et al.  Cobalt(II) inhibits the incision and the polymerization step of nucleotide excision repair in human fibroblasts. , 1997, Mutation research.

[25]  L. A. Gallenberg,et al.  Transfer of persistent chemicals in milk. , 1989, Drug metabolism reviews.

[26]  S. Cohen,et al.  Rodent bladder tumors do not always predict for humans. , 1995, Cancer letters.

[27]  F. Kadlubar,et al.  Aromatic amine acetyltransferase as a marker for colorectal cancer: Environmental and demographic associations , 1990, International journal of cancer.

[28]  A Poland,et al.  2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. , 1982, Annual review of pharmacology and toxicology.

[29]  W. Calder,et al.  Body Size, Physiological Time, and Longevity of Homeothermic Animals , 1981, The Quarterly Review of Biology.

[30]  A G Renwick,et al.  An analysis of the possibility for health implications of joint actions and interactions between food additives. , 2000, Regulatory toxicology and pharmacology : RTP.

[31]  D. Gaylor,et al.  Journal Abstracts , 1979, Journal of environmental pathology and toxicology.

[32]  C. Paraskeva,et al.  The short-chain fatty acid butyrate induces apoptosis in colorectal tumour cell lines. , 1995, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[33]  R. Hughes,et al.  Stimulation of apoptosis by two prebiotic chicory fructans in the rat colon. , 2001, Carcinogenesis.

[34]  F. Kadlubar,et al.  Role of aromatic amine acetyltransferase in human colorectal cancer. , 1986, Archives of surgery.

[35]  I. Rowland,et al.  Lactobacillus- and bifidobacterium-mediated antigenotoxicity in the colon of rats. , 1996, Nutrition and cancer.

[36]  M. Pieters,et al.  Evaluation of the uncertainty factor for subchronic-to-chronic extrapolation: statistical analysis of toxicity data. , 1998, Regulatory toxicology and pharmacology : RTP.

[37]  A G Renwick,et al.  Human variability and noncancer risk assessment--an analysis of the default uncertainty factor. , 1998, Regulatory toxicology and pharmacology : RTP.

[38]  I. Munro,et al.  Alternative approaches to the safety assessment of macronutrient substitutes. , 1996, Regulatory toxicology and pharmacology : RTP.

[39]  R. Glashan,et al.  ROLE OF N-ACETYLTRANSFERASE PHENOTYPES IN BLADDER CARCINOGENESIS: A PHARMACOGENETIC EPIDEMIOLOGICAL APPROACH TO BLADDER CANCER , 1982, The Lancet.

[40]  C. Gennings,et al.  Economical designs for detecting and characterizing departure from additivity in mixtures of many chemicals. , 1996, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[41]  S. Safe,et al.  Environmental and dietary estrogens and human health: is there a problem? , 1995, Environmental health perspectives.

[42]  H. Til,et al.  Subchronic oral toxicity study with regular and enzymatically depolymerized sodium carboxymethylcellulose in rats. , 1995, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[43]  A. Hartwig,et al.  Interaction of arsenic(III) with nucleotide excision repair in UV-irradiated human fibroblasts. , 1997, Carcinogenesis.

[44]  A. Dahl,et al.  Nasal cavity enzymes involved in xenobiotic metabolism: effects on the toxicity of inhalants. , 1991, Critical reviews in toxicology.

[45]  J. Miller,et al.  THE COMPARATIVE CARCINOGENICITIES OF 2-ACETYLAMINOFLUORENE AND ITS N-HYDROXY METABOLITE IN MICE, HAMSTERS, AND GUINEA PIGS. , 1964, Cancer research.

[46]  M. Fromm,et al.  P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs. , 2000, International journal of clinical pharmacology and therapeutics.

[47]  J. Tuomisto,et al.  Physicochemical differences in the AH receptors of the most TCDD-susceptible and the most TCDD-resistant rat strains. , 1999, Toxicology and applied pharmacology.

[48]  T. Kensler,et al.  Chemoprotection by Organosulfur Inducers of Phase 2 Enzymes: Dithiolethiones and Dithiins , 2000, Drug metabolism and drug interactions.

[49]  U. Thorgeirsson,et al.  Tumor incidence in a chemical carcinogenesis study of nonhuman primates. , 1994, Regulatory toxicology and pharmacology : RTP.

[50]  J M Ward,et al.  Receptor and Nonreceptor-Mediated Organ-Specific Toxicity of Di(2-ethylhexyl)phthalate (DEHP) in Peroxisome Proliferator-Activated Receptorα-Null Mice , 1998, Toxicologic pathology.

[51]  M. Kelly,et al.  Lack of carcinogenic activity and metabolic fate of fluorenylacetamides in monkeys. , 1966, Journal of the National Cancer Institute.

[52]  M. Pirmohamed,et al.  Metabolic activation in drug allergies. , 2001, Toxicology.

[53]  Safe,et al.  Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. , 1998, Environmental health perspectives.

[54]  Hypnotics and sedatives , 1986 .

[55]  F. Guarner,et al.  Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat , 2001, American Journal of Gastroenterology.

[56]  J. Kolars,et al.  First-pass metabolism of cyclosporin by the gut , 1991, The Lancet.

[57]  E. Schoen Statistical designs in combination toxicology: a matter of choice. , 1996, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[58]  D. Gaylor,et al.  Relative potency of chemical carcinogens in rodents. , 1986, Risk analysis : an official publication of the Society for Risk Analysis.

[59]  A. Hartwig,et al.  S9/L3 - Carcinogenicity of metal compounds , 1998 .

[60]  J A Miller,et al.  Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture. , 1970, Cancer research.

[61]  M Balls,et al.  Methods of in vitro toxicology. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[62]  C. I. Bliss THE TOXICITY OF POISONS APPLIED JOINTLY1 , 1939 .

[63]  B. Oser The rat as a model for human toxicological evaluation. , 1981, Journal of toxicology and environmental health.

[64]  E. Calabrese,et al.  Can the concept of hormesis Be generalized to carcinogenesis? , 1998, Regulatory toxicology and pharmacology : RTP.

[65]  B B Brodie,et al.  Possible mechanism of liver necrosis caused by aromatic organic compounds. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[66]  A G Renwick,et al.  Safety factors and establishment of acceptable daily intakes. , 1991, Food additives and contaminants.

[67]  W. Mertz,et al.  Risk assessment of essential trace elements: new approaches to setting recommended dietary allowances and safety limits. , 2009, Nutrition reviews.

[68]  Sac-fry Stages,et al.  OECD GUIDELINE FOR TESTING OF CHEMICALS , 2002 .

[69]  B D Beck,et al.  Does the animal-to-human uncertainty factor incorporate interspecies differences in surface area? , 1992, Regulatory toxicology and pharmacology : RTP.

[70]  K. Ilett,et al.  Acetylation phenotype in colorectal carcinoma. , 1987, Cancer research.

[71]  A T Eldefrawi,et al.  Receptors for γ‐aminobutyric acid and voltage‐dependent chloride channels as targets for drugs and toxicants 1 , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[72]  D G Hattan,et al.  FDA's priority-based assessment of food additives. III. Specific toxicity parameters. , 1985, Regulatory toxicology and pharmacology : RTP.

[73]  C. Schlatter,et al.  The Effect of Pregnancy on the Pharmacokinetics of Caffeine , 1981 .

[74]  A. Huggett,et al.  An integrated in vivo and in vitro strategy to improve food safety evaluation , 1996 .

[75]  J. Radomski The primary aromatic amines: their biological properties and structure-activity relationships. , 1979, Annual review of pharmacology and toxicology.

[76]  R. Bronson,et al.  Effects of caloric restriction or augmentation in adult rats: Longevity and lesion biomarkers of aging , 1998, Aging.

[77]  E. Dybing,et al.  Situations with enhanced chemical risks due to toxicokinetic and toxicodynamic factors. , 1999, Regulatory toxicology and pharmacology : RTP.

[78]  J. Hook,et al.  Toxicology of the Kidney , 1992 .

[79]  L. Valcovic,et al.  Hazard evaluation of chemicals that cause accumulation of alpha 2u-globulin, hyaline droplet nephropathy, and tubule neoplasia in the kidneys of male rats. , 1993, Environmental health perspectives.

[80]  G. Corcoran,et al.  The role of the nucleus and other compartments in toxic cell death produced by alkylating hepatotoxicants. , 1992, Toxicology and applied pharmacology.

[81]  K. Dalton Toxicity of vitamins. , 1986 .

[82]  J. French,et al.  Roles for insulin-like growth factor-1 in mediating the anti-carcinogenic effects of caloric restriction. , 1999, The journal of nutrition, health & aging.

[83]  I. Dreosti Nutrition, Cancer, and Aging , 1998, Annals of the New York Academy of Sciences.

[84]  F. Lu,et al.  Safety assessments of chemicals with thresholded effects. , 1985, Regulatory toxicology and pharmacology : RTP.

[85]  A. Renwick Data-derived safety factors for the evaluation of food additives and environmental contaminants. , 1993, Food additives and contaminants.

[86]  E. Gallagher,et al.  Mechanisms of aflatoxin carcinogenesis. , 1994, Annual review of pharmacology and toxicology.

[87]  J. Swenberg Bioassay design and MTD setting: old methods and new approaches. , 1995, Regulatory toxicology and pharmacology : RTP.

[88]  C J Portier,et al.  Effects of glutathione transferase theta polymorphism on the risk estimates of dichloromethane to humans. , 1999, Toxicology and applied pharmacology.

[89]  C. Powell,et al.  The dose-dependent effect of BHT (butylated hydroxytoluene) on vitamin K-dependent blood coagulation in rats. , 1994, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[90]  M M Mumtaz,et al.  A Weight-of-Evidence Approach for Assessing Interactions in Chemical Mixtures , 1992, Toxicology and industrial health.

[91]  Roeters Fj Perspectives in carbohydrate toxicology with special reference to carcinogenicity. , 1984 .

[92]  E. Poulsen Case study: erythrosine. , 1993, Food additives and contaminants.

[93]  M. W. Anders Bioactivation of foreign compounds , 1985 .

[94]  Rudolfs K. Zalups,et al.  Molecular biology and toxicology of metals , 2000 .

[95]  M L Dourson,et al.  Regulatory history and experimental support of uncertainty (safety) factors. , 1983, Regulatory toxicology and pharmacology : RTP.

[96]  M. Tomita,et al.  Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. , 1997, Carcinogenesis.

[97]  R. Hayes,et al.  N-acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers. , 1993, Carcinogenesis.

[98]  F. Roe,et al.  Enzootic and Epizootic Adrenal Medullary Proliferative Disease of Rats: Influence of Dietary Factors which Affect Calcium Absorption , 1985, Human toxicology.

[99]  Thomson,et al.  Review article: olestra and its gastrointestinal safety , 1998, Alimentary pharmacology & therapeutics.

[100]  M. R. Boyd,et al.  Biochemical mechanisms in chemical-induced lung injury: roles of metabolic activation. , 1980, Critical reviews in toxicology.

[101]  F. Roe The Leon Golberg Memorial Lecture. Recent advances in toxicology relevant to carcinogenesis: seven cameos. , 1993, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[102]  W. H. Farland,et al.  Workshop report on EPA (Environmental Protection Agency) guidelines for carcinogen risk assessment. Held in Virginia Beach, Virginia on January 11-13, 1989 , 1989 .

[103]  A. Monro The paradoxical lack of interspecies correlation between plasma concentrations and chemical carcinogenicity. , 1993, Regulatory toxicology and pharmacology : RTP.

[104]  R K Jain,et al.  Physiologically based pharmacokinetic modeling: principles and applications. , 1983, Journal of pharmaceutical sciences.

[105]  J N Hathcock,et al.  Safety limits for nutrient intakes: concepts and data requirements. , 2009, Nutrition reviews.

[106]  I. Rowland,et al.  Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. , 1998, Carcinogenesis.

[107]  John P. Groten,et al.  Sensory irritation to mixtures of formaldehyde, acrolein, and acetaldehyde in rats , 1996, Archives of Toxicology.

[108]  C. Rao,et al.  Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. , 1997, Carcinogenesis.

[109]  D G Hoel,et al.  Fundamental carcinogenic processes and their implications for low dose risk assessment. , 1976, Cancer research.

[110]  J. Groten,et al.  Toxicological evaluation and risk assessment of chemical mixtures. , 1998, Critical reviews in toxicology.

[111]  S. Safe,et al.  Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. , 1986, Annual review of pharmacology and toxicology.

[112]  J. Groopman,et al.  Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. , 1987, Cancer research.

[113]  J. Caldwell Chapter 5 – Comparative Aspects of Detoxication in Mammals , 1980 .

[114]  H. Sies,et al.  Oxidative stress: oxidants and antioxidants , 1997, Experimental physiology.

[115]  W. Vogel The Effect of Stress on Toxicological Investigations , 1993, Human & experimental toxicology.

[116]  R Truhaut,et al.  The concept of the acceptable daily intake: an historical review. , 1991, Food additives and contaminants.

[117]  M. Brodie,et al.  Drug metabolism in liver disease. , 1989, Pharmacology & therapeutics.

[118]  W. Slob,et al.  Mathematical modelling and quantitative methods. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[119]  I W Davidson,et al.  Biological basis for extrapolation across mammalian species. , 1986, Regulatory toxicology and pharmacology : RTP.

[120]  J. Gustafsson,et al.  Sex steroid induced changes in hepatic enzymes. , 1983, Annual review of physiology.

[121]  Linda S. Birnbaum,et al.  Consultation on assessment of the health risk of dioxins; re-evaluation of the tolerable daily intake (TDI): executive summary. , 2000, Food additives and contaminants.

[122]  A. Conney,et al.  Regulation of drug metabolism in man by environmental chemicals and diet. , 1977, Federation proceedings.

[123]  William B. Jakoby,et al.  Enzymatic basis of detoxication , 1980 .

[124]  W Slob,et al.  Assessment factors for human health risk assessment: a discussion paper. , 1999, Critical reviews in toxicology.

[125]  A. Hartwig,et al.  Disturbance of DNA damage recognition after UV-irradiation by nickel(II) and cadmium(II) in mammalian cells. , 1998, Carcinogenesis.

[126]  Mark D. Hoover,et al.  Disposition of polycyclic aromatic hydrocarbons in the respiratory tract of the beagle dog. I. The alveolar region. , 1993, Toxicology and applied pharmacology.

[127]  K. Herrold Aflatoxin induced lesions in Syrian hamsters. , 1969, British Journal of Cancer.

[128]  H. Wolf,et al.  N-Acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark , 1979, Environmental health perspectives.

[129]  M A Butler,et al.  Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[130]  J W Bridges,et al.  Hazard identification by methods of animal-based toxicology. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[131]  W. Slob,et al.  A Probabilistic Approach for Deriving Acceptable Human Intake Limits and Human Health Risks from Toxicological Studies: General Framework , 1998 .

[132]  B. Trump,et al.  Calcium‐mediated cell injury and cell death , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[133]  R. Mcclain Mechanistic considerations for the relevance of animal data on thyroid neoplasia to human risk assessment. , 1995, Mutation research.

[134]  S. Cohen,et al.  Role of urinary physiology and chemistry in bladder carcinogenesis. , 1995, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[135]  H. Kay Environmental Health Criteria , 1980 .

[136]  R. Truhaut Potential Carcinogenic Hazards from Drugs , 1967, UICC Monograph Series.

[137]  S. Anttila,et al.  Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility--a review. , 1995, Gene.

[138]  D A Jonas,et al.  The safety assessment of novel foods. Guidelines prepared by ILSI Europe Novel Food Task Force. , 1996, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[139]  J. Erdman,et al.  Phytic acid in health and disease. , 1995, Critical reviews in food science and nutrition.

[140]  Wr. Hobbs,et al.  Hypnotics and sedatives; ethanol , 1996 .

[141]  J. Mordenti,et al.  Man versus beast: pharmacokinetic scaling in mammals. , 1986, Journal of pharmaceutical sciences.

[142]  D. Umbenhauer,et al.  Disposition of ivermectin and cyclosporin A in CF-1 mice deficient in mdr1a P-glycoprotein. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[143]  S. Wrighton,et al.  The human hepatic cytochromes P450 involved in drug metabolism. , 1992, Critical reviews in toxicology.

[144]  P. Harper,et al.  Molecular biology of the aromatic hydrocarbon (dioxin) receptor. , 1994, Trends in pharmacological sciences.

[145]  M. Abdel‐Rahman,et al.  Evaluation of the use of uncertainty factors in deriving RfDs for some chlorinated compounds. , 1995, Journal of toxicology and environmental health.

[146]  H M Bolt,et al.  Experimental designs and risk assessment in combination toxicology: panel discussion. , 1996, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[147]  E. Schoen,et al.  Statistically designed experiments in a tiered approach to screen mixtures of Fusarium mycotoxins for possible interactions. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[148]  D. Hicks,et al.  Apoptosis in colorectal tumour cells: Induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate , 1995, International journal of cancer.

[149]  P. Copestake Information sectionThe acceptable daily intake , 1989 .

[150]  E. Kriek,et al.  On the mechanism of action of carcinogenic aromatic amines. I. Binding of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene to rat-liver nucleic acids in vivo. , 1969, Chemico-biological interactions.

[151]  M. Blaut,et al.  Effects of inulin on faecal bifidobacteria in human subjects , 1999, British Journal of Nutrition.

[152]  V. Feron,et al.  Toxicity of mixtures of nephrotoxicants with similar or dissimilar mode of action. , 1996, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[153]  J I Goodman,et al.  Principles underlying dose selection for, and extrapolation from, the carcinogen bioassay: dose influences mechanism. , 1995, Regulatory toxicology and pharmacology : RTP.

[154]  R. Henderson,et al.  Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene. , 1995, Carcinogenesis.

[155]  Wout Slob,et al.  Thresholds in Toxicology and Risk Assessment , 1999 .

[156]  D. Shen,et al.  Oral first‐pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A‐mediated metabolism , 1996, Clinical pharmacology and therapeutics.

[157]  G Würtzen,et al.  Threshold of toxicological concern for chemical substances present in the diet: a practical tool for assessing the need for toxicity testing. , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[158]  Gunnar F. Nordberg,et al.  Principles and Methods for the Assessment of Risk from Essential Trace Elements , 2002 .

[159]  H Boeing,et al.  The contribution of epidemiology. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[160]  B. Rumack,et al.  Acetaminophen poisoning and toxicity. , 1975, Pediatrics.

[161]  J. Haist,et al.  INCREASED DIETARY CADMIUM ABSORPTION IN MICE AND HUMAN SUBJECTS WITH IRON DEFICIENCY , 1978 .

[162]  Mark S. Boyce,et al.  Seasonality, Fasting Endurance, and Body Size in Mammals , 1985, The American Naturalist.

[163]  E. Dybing,et al.  Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis. Proceedings of a consensus conference. Lyon, France, 3-7 November 1997. , 1999, IARC scientific publications.

[164]  L. Shuker,et al.  ILSI Europe Workshop on Assessing Health Risks From Environmental Exposure to Chemicals: the Example of Drinking Water. Summary Report. International Life Sciences Institute. , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[165]  J. Ashby,et al.  Safety evaluation of phytosterol esters. Part 1. Assessment of oestrogenicity using a combination of in vivo and in vitro assays. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[166]  J. Borzelleca The safety evaluation of macronutrient substitutes. , 1992, Critical reviews in food science and nutrition.

[167]  J. Mordenti,et al.  Pharmacokinetic scale-up: accurate prediction of human pharmacokinetic profiles from animal data. , 1985, Journal of pharmaceutical sciences.

[168]  B. Krajewska,et al.  Acetylation phenotypes and bladder cancer. , 1990, Journal of occupational medicine. : official publication of the Industrial Medical Association.

[169]  C. Walker Species differences in microsomal monooxygenase activity and their relationship to biological half-lives. , 1978, Drug metabolism reviews.

[170]  M L Dourson,et al.  Evolution of science-based uncertainty factors in noncancer risk assessment. , 1996, Regulatory toxicology and pharmacology : RTP.

[171]  F. A. Smith,et al.  Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. , 1987, Toxicology and applied pharmacology.

[172]  I. Purchase,et al.  Thresholds in chemical carcinogenesis. , 1995, Regulatory toxicology and pharmacology : RTP.

[173]  B. Brodie,et al.  Species, strain and sex differences in metabolism of hexobarbitone, amidopyrine, antipyrine and aniline , 1958 .

[174]  John L. Adgate,et al.  Subchronic to chronic exposure extrapolation: Toxicologic evidence for a reduced uncertainty factor , 1995 .

[175]  Fumio Matsumura,et al.  Toxicology of Insecticides , 1975, Springer US.

[176]  W. Flamm,et al.  The human relevance of the renal tumor-inducing potential of d-limonene in male rats: implications for risk assessment. , 1991, Regulatory toxicology and pharmacology : RTP.

[177]  M. Pike,et al.  A carcinogenic potency database of the standardized results of animal bioassays , 1984, Environmental health perspectives.

[178]  D G Hoel,et al.  Nonlinearity of dose-response functions for carcinogenicity. , 1994, Environmental health perspectives.

[179]  A. Hartwig Carcinogenicity of metal compounds: possible role of DNA repair inhibition. , 1998, Toxicology letters.

[180]  A. Vercesi,et al.  Mitochondrial Effects of Triarylmethane Dyes , 1999, Journal of bioenergetics and biomembranes.

[181]  S. Cohen,et al.  Calcium phosphate-containing urinary precipitate in rat urinary bladder carcinogenesis. , 1999, IARC scientific publications.

[182]  S. Nelson,et al.  The role of metabolic activation in drug toxicity. , 1994, Drug metabolism reviews.